This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
5/7/2026
Operator
Conference Operator
only ask one question and one follow-up. Please stand by while we compile the Q&A roster. Our first question comes from the line of Jed Dorsheimer of William Blair. Your line is now open.
Jed Dorsheimer
Analyst, William Blair
Hey, thanks, guys. I was just wondering, Russell, maybe you could I know that gallium nitride and indium phosphide are mostly deposition, which makes your merger that much more exciting. But there is some implant associated with containment, et cetera. So I was wondering if you might just, you know, spend a minute just talking about that opportunity, and then I have a follow-up. Thanks.
Russell
Chief Technology Officer, Xelis
Yeah. Hi, Jed. So are you talking about the implant opportunity in silicon photonics, particularly in data centers? Is that where you're heading?
You're reading a preview of the ACLS Q1 2026 earnings call.
Free account.
Disclaimer